These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34740359)

  • 101. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.
    Yeung AM; Huang J; Pandey A; Hashim IA; Kerr D; Pop-Busui R; Rhee CM; Shah VN; Bally L; Bayes-Genis A; Bee YM; Bergenstal R; Butler J; Fleming GA; Gilbert G; Greene SJ; Kosiborod MN; Leiter LA; Mankovsky B; Martens TW; Mathieu C; Mohan V; Patel KV; Peters A; Rhee EJ; Rosano GMC; Sacks DB; Sandoval Y; Seley JJ; Schnell O; Umpierrez G; Waki K; Wright EE; Wu AHB; Klonoff DC
    Prog Cardiovasc Dis; 2023; 79():65-79. PubMed ID: 37178991
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost-effectiveness analysis.
    Horton WB; Dart ME; Kavuru VS; Girton MR; Jin R
    Diabetes Obes Metab; 2024 Nov; 26(11):5470-5473. PubMed ID: 39161067
    [No Abstract]   [Full Text] [Related]  

  • 103. Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
    Lee KS; Noh J; Park SM; Choi KM; Kang SM; Won KC; Cho HJ; Moon MK
    Diabetes Metab J; 2023 Jan; 47(1):10-26. PubMed ID: 36727161
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Rethinking the Impact and Management of Diabetes in Heart Failure Patients.
    Schütt K
    Curr Heart Fail Rep; 2024 Feb; 21(1):53-60. PubMed ID: 38047986
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Prevalence of heart failure diagnosed in diabetic patients in the primary care setting. Should we improve screening?].
    Sánchez Molla M; Zazo Menargues JM; Candela Garcia I
    Aten Primaria; 2024 Jul; 56(7):102952. PubMed ID: 38718693
    [No Abstract]   [Full Text] [Related]  

  • 106. Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
    Lee KS; Noh J; Park SM; Choi KM; Kang SM; Won KC; Cho HJ; Moon MK;
    Int J Heart Fail; 2023 Jan; 5(1):1-20. PubMed ID: 36818141
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
    Filippatos G; Anker SD; Agarwal R; Ruilope LM; Rossing P; Bakris GL; Tasto C; Joseph A; Kolkhof P; Lage A; Pitt B;
    Circulation; 2022 Feb; 145(6):437-447. PubMed ID: 34775784
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
    Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G
    Front Endocrinol (Lausanne); 2021; 12():738848. PubMed ID: 34745006
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Heart Failure With Preserved Ejection Fraction: A Review.
    Redfield MM; Borlaug BA
    JAMA; 2023 Mar; 329(10):827-838. PubMed ID: 36917048
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study.
    Ku EJ; Lee DH; Jeon HJ; Oh TK
    Diabetes Res Clin Pract; 2021 Dec; 182():109123. PubMed ID: 34740742
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Molnupiravir in COVID-19: A systematic review of literature.
    Singh AK; Singh A; Singh R; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102329. PubMed ID: 34742052
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial.
    Omar M; Jensen J; Burkhoff D; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Gustafsson F; Køber L; Borlaug BA; Schou M; Møller JE
    Circ Heart Fail; 2022 Mar; 15(3):e009156. PubMed ID: 34743533
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
    Berg DD; Docherty KF; Sattar N; Jarolim P; Welsh P; Jhund PS; Anand IS; Chopra V; de Boer RA; Kosiborod MN; Nicolau JC; O'Meara E; Schou M; Hammarstedt A; Langkilde AM; Lindholm D; Sjöstrand M; McMurray JJV; Sabatine MS; Morrow DA
    Circulation; 2022 Jan; 145(3):158-169. PubMed ID: 34743554
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis.
    Chen C; Peng H; Li M; Lu X; Huang M; Zeng Y; Dong G
    Front Endocrinol (Lausanne); 2021; 12():664533. PubMed ID: 34759887
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
    Filippatos G; Butler J; Farmakis D; Zannad F; Ofstad AP; Ferreira JP; Green JB; Rosenstock J; Schnaidt S; Brueckmann M; Pocock SJ; Packer M; Anker SD;
    Circulation; 2022 Aug; 146(9):676-686. PubMed ID: 35762322
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.
    Pop-Busui R; Januzzi JL; Bruemmer D; Butalia S; Green JB; Horton WB; Knight C; Levi M; Rasouli N; Richardson CR
    Diabetes Care; 2022 Jul; 45(7):1670-1690. PubMed ID: 35796765
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet; 2022 Jan; 399(10320):143-151. PubMed ID: 34800427
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients: a meta-analysis of randomized clinical trials.
    Bazoukis G; Papadatos SS; Thomopoulos C; Tse G; Cheilidis S; Tsioufis K; Farmakis D
    J Geriatr Cardiol; 2021 Oct; 18(10):783-795. PubMed ID: 34754290
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus.
    Pitt B; Steg G; Leiter LA; Bhatt DL
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):561-567. PubMed ID: 34750713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.